Fig. 1From: Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgeryPatient scans. a Chest computed tomography scan: pre-tyrosine kinase inhibitors (TKI) therapy in March 2017. b Post-TKI therapy and pre-surgery in November 2018; right lower lobe lung mass regressed but noticeable. c Whole body bone scan: pre-TKI in March 2017. d During TKI therapy in July 2018Back to article page